CBA shares soared last year and finished well in the green, but has the time come to unload the banking stock? Let's dive in ...

Key Takeaways The Zacks Consensus Estimate for JNJ Q4 sales and earnings is $22.5 billion and $2.01 per share, respectively.

Congress has an unusual ability to make remarkably well-timed stock trades. Cross their hearts, they are not buying and ...

SpaceM will allow creators to transform engaging posts into NFTs and sell them directly to fans. As content gains traction ...

Key Takeaways SLB had Q4 2024 earnings of 92 cents per share, which beat the Zacks Consensus Estimate of 90 cents. The ...

Real estate stocks staged a comeback in 2024 after underperforming in the prior three years as the sector was still recovering from the pain of Covid lockdowns. A repeat of this enthusiasm in 2025 ...

President-elect Donald Trump has launched a new cryptocurrency token that is soaring in value—and potentially boosting his ...

Zumiez's expansion of private-label products, new brands and focus on cost efficiency position it for growth despite recent ...

These FTSE-listed shares have dropped sharply in recent times. But Royston Wild thinks 2025 could be the year of the comeback ...

Highlights:,Earnings momentum refers to the growth in earnings per share (EPS) over consecutive periods.,It signals an upward ...

TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.